CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response

Karol Szlachta(University of Virginia), Mazhar Adli(Northwestern University)
Nature Communications
October 9, 2018
Cited by 78


Related Papers